The Effect of Team Sports on the Risk of Thrombosis in Elderly Individuals in a Municipality Setting (TEAM-AGE)

Launched by UNIVERSITY OF COPENHAGEN · Oct 26, 2020

Keywords

ClinConnect Summary

The TEAM-AGE trial is studying how playing team sports might help reduce the risk of dangerous blood clots, known as thrombosis, in older adults. This research is important because cardiovascular diseases, like heart attacks, are a leading cause of death, especially in people aged 60-70. The study will look at how regular physical activity, particularly through team sports, can improve heart health, affect blood clot formation, and boost the growth of tiny blood vessels that are vital for good circulation. The researchers want to understand if there are any differences between men and women in how their bodies respond to this activity.

To participate in this trial, individuals should be between 60 and 70 years old and currently engage in less than 2 hours of physical activity per week (not including walking or biking for transportation). They should also have a body mass index (BMI) of 30 or less. Participants will not be allowed to join if they are younger than 60, have any significant injuries, smoke, or have certain health conditions. Those who qualify will engage in team sports and undergo various health assessments to see how their bodies respond. This trial is not yet recruiting participants, but it aims to provide valuable insights into how exercise can benefit older adults' health.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age: 60-70 years
• • Physical activity ≤ 2 hours per week (except transportation by bike or by walking)
• • BMI ≤ 30
• Exclusion Criteria:
• • Age \<60 years
• • Injuries that prevent the performance of team sports
• • Participation in other clinical projects
• • Smokes or has smoked within the last 10 years
• • On hormone therapy (women)
• • Not entered menopause (women)
• • Has chronic diseases that are not expected, cf. the groups sought. Including heart problems, atrial fibrillation, cancer, immune diseases and previous strokes with functionally significant sequelae
• • Being treated with oral steroids
• • Has alcohol / drug abuse or is being treated with disulfiram (Antabus)
• • Is unable to understand the contents of the document with informed consent or the experimental procedures